stockrowTeva Pharmaceutical Industries Ltd. (TEVA) vs Viatris Inc. (VTRS)
- Teva Pharmaceutical Industries Ltd. TEVA 41.73 −0.29%
- Viatris Inc. VTRS 18.89 −1.72%
Teva Pharmaceutical Industries Ltd. and Viatris Inc. are both Drug Manufacturers Specialty & Generic companies. Teva Pharmaceutical Industries Ltd. is the larger, with a market value of $48.7B against $21.8B — 2.2× the size. Viatris Inc. has negative trailing earnings, so its P/E is not meaningful; Teva Pharmaceutical Industries Ltd. trades at 92.6×. Viatris Inc. grew revenue faster over the last twelve months: 4.27% against 2.71%. Teva Pharmaceutical Industries Ltd. has the higher net margin (2.94% vs −4.13%) and the higher return on invested capital (4.09% vs −0.02%). Across the 20 metrics below, Viatris Inc. leads on 11 and Teva Pharmaceutical Industries Ltd. on 9.
Valuation
Profitability
| Metric | TEVA | VTRS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 53.51% | 35.31% | 53.51% |
| Operating margin | 7.84% | (0.03%) | 0.00% |
| Net margin | 2.94% | (4.13%) | (2.45%) |
| Free cash flow margin | 7.71% | 16.27% | 0.00% |
| Return on equity | 6.65% | (4.21%) | (0.80%) |
| Return on assets | 1.27% | (1.67%) | (1.67%) |
| Return on invested capital | 4.09% | (0.02%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack